McKesson Releases Specialty Rx Criteria To Its Flagship Acute Criteria Product

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Leadership at NHS Hospitals in Leeds...

A watchdog has gone on to say that the...

Developing Dr. CaBot, A Medical Education...

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for...

The medicines regulator of the UK has announced plans...
McKesson announced the release of the InterQual 2011 solution, introducing condition specific criteria to its flagship acute criteria product, a new specialty pharmaceutical criteria set, and acute criteria inside McKesson’s Clear Coverage ™ point of care, decision support platform. These innovations combine to add significant clinical criteria and automation, while building upon InterQual’s long-standing focus on increasing efficiencies, appropriateness of care, and patient outcomes with the industry’s leading evidence-based clinical decision support tool.

A. Jacqueline Mitus, MD, senior vice president of clinical development and strategy for McKesson Health Solutions said, It is remarkable to look back at the 35-year evolution of InterQual and the innovations in clinical content and technology that we have brought to the market. It’s rewarding to see how our payer, hospital and government customers continue to embrace InterQual and work closely with us to enhance it year after yea

Latest stories

Related stories

Developing Dr. CaBot, A Medical Education Tool That Reasons

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for Medtech Regulatory Reforms

The medicines regulator of the UK has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »